Fig. 2: Comparison of visual function in symptomatic and asymptomatic patients with hydroxychloroquine retinopathy at diagnosis. | Eye

Fig. 2: Comparison of visual function in symptomatic and asymptomatic patients with hydroxychloroquine retinopathy at diagnosis.

From: The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom

Fig. 2

A Visual acuity was significantly better at diagnosis in the asymptomatic patients detected as a result of monitoring, compared to those who presented with visual symptoms (median logMAR 0.1 vs. 0.22; p = 0.007; Mann–Whitney two-tailed test; n = 70). B Mean deviation on 10-2 visual field testing was significantly preserved in the asymptomatic vs. symptomatic groups (p = 0.017; median MD −3.73 dB vs. −8.69 dB; Mann–Whitney two-tailed test; n = 34). C–E No differences were observed between asymptomatic and symptomatic patients based on duration of hydroxychloroquine exposure (p = 0.33), age at diagnosis (p = 0.73) or daily dose (p = 0.43).

Back to article page